◆ 會議時間：2026年9月29日-10月1日
◆ 會議地點：日本 京都
◆ 會議簡介：
2026年第46屆SICOT世界骨科大會將于2026年9月29日-10月1日在日本京都舉行，會議由國際矯形與創傷外科學會(SICOT)組織。SICOT世界骨科大會(OWC)是全球骨科學領域的最具影響力的國際盛會之一，每年都會吸引來自全球100多個國家的3000余名專業人士與會，一起分享交流骨科領域的經驗和最新的研究成果。
國際矯形與創傷外科學會(SICOT)/世界骨科組織是世界矯形外科與創傷外科領域宣最具權威的國際性學術組織之一，于1929年在法國巴黎成立，現總部位于比利時布魯塞爾。SICOT專注于在全球范圍內推動骨科與創傷科學的進步，提升患者的護理水平，發展教學、研究與教育，促進和鼓勵成員間專業經驗的交流。未經許可禁止復制轉載鏡像本站任何內容-國際醫學會議網(lingyuint.com)。
46th SICOT Orthopaedic World Congress (SICOT 2026)
Date:
29 September ‐ 1 October 2026
Location:
Kyoto, Japan
Organized by:
Société Internationale de Chirurgie Orthopédique et de Traumatologie
International Society of Orthopaedic Surgery and Traumatology (SICOT)
摘要征文投稿：
28 February 2026
Abstract Submission Extended Deadline
點此提交摘要>>>Submit Abstract>>>
SICOT welcomes you to submit scientific abstracts to the 46th Orthopaedic World Congress (OWC 2026). Abstract submission is open to both SICOT members and non-members. You may submit abstracts in two categories:?podium presentations?or?e-posters.??
?Podium presentations are either??
- Free Papers (5 minutes presentation + 1 minute discussion
OR
- Short Free Papers (3 minutes presentation + 1 minute discussion)?
Allocation of abstracts into Free Papers or Short Free Papers will be based on scoring by peer reviewers and at the discretion of the Scientific Programme Committee.??
Top-scoring abstracts selected for e-poster display are eligible for a 1-minute presentation at the JAM (Just-A-Minute) sessions.??
At submission, authors can choose to have any abstracts that are submitted for podium presentation but not accepted to be considered for e-poster display.?
KEY DATES?
Programme submission deadline: 15 February 2026?
Notification of abstract acceptance:early?April 2026?
Deadline for?early?registration (with payment) for presenting authors:30 April?2026
GUIDELINES?
- The presenting author must submit the abstracts.
If the presenting author must be changed after submission, contact
sicot-abstracts@kit-group.org, indicating the abstract reference number, the full name, email address, institution and proof of consent of the new presenting author.?
- Abstracts must be submitted online via the abstract submission portal. Emailed abstracts will not be accepted.?
- Do not use all upper-case letters when entering your abstract text.?
- Abstracts must not exceed 250 words in length.?
- Graphs, tables, photographs or slides are not allowed
- Abstracts must be written in English. We highly recommend that the?abstract is proofread for spelling and grammar errors?by a fluent English speaker before submission. Abstracts written in poor English are less likely to be accepted
- The abstract’s title or authors’ names or affiliations must NOT appear in the body of the abstract. If these are disclosed in the abstract, that abstract will be?disqualified.?
- Authors’ given and family names must be spelled out in full.?Please do not use any initials
- The co-authors must be included in the list of authors at the time of submission and cannot be added later.?
- A maximum of 5 abstracts for podium presentations can be submitted per presenter. There is no restriction for e-poster submissions.??
- Each presenter can present?a maximum of 2 podium presentations?at the OWC. If more than 2 podium presentations are accepted for a single presenter, then a co-author must be nominated to present on the main author’s behalf
- Case reports will only be accepted as e-Poster.??
TERMS AND CONDITIONS??
The material submitted must not have been published in a journal nor presented at any national or international meeting before OWC 2026.
Submission of an abstract implies that the presenting author will register for and attend the OW 2026 Congress in Kyoto to present their accepted abstract(s) either as a podium presentation or as an e-poster. Certificates of Presentation will not be issued to presenters who do not attend the Congress and give their presentation(s) in the relevant session(s).??
‘No-show’ presenters will also be barred from submitting abstracts to the next SICOT Orthopaedic World Congress in 2027.
The Scientific Programme Committee reserves the right to change the topic and the form of presentation (free paper, short free paper, Just-a-Minute (JAM) paper, and e-poster) of the abstract or to reject it.?
Dear Colleagues, Friends, and Distinguished Guests,
On behalf of the Organizing Committee and our international partners, it is my great honor and privilege to welcome you to the Orthopaedic World Congress 2026, to be held in the beautiful and historic city of Kyoto, Japan, from 29 September to 1 October 2026.
Our theme, “A Bridge to the Future”, captures the spirit of this moment in orthopaedic science and practice. We stand at the intersection of tradition and innovation, where timeless surgical principles meet transformative technologies—from robotics and regenerative medicine to AI-driven diagnostics and personalized care. This Congress will serve as a platform to connect generations of orthopaedic professionals, cross-pollinate ideas across disciplines, and build meaningful collaborations that transcend borders.
Kyoto, with its rich cultural legacy and serene landscapes, provides the perfect setting to reflect on our shared past and envision the road ahead. From its ancient temples to its cutting-edge research institutions, the city symbolizes the harmonious blending of history and progress—much like our field today.
The Congress will feature a robust scientific program including keynote lectures by global thought leaders, interactive symposia, hands-on workshops, and networking events designed to foster dialogue, discovery, and development. Whether you are a seasoned expert or an emerging voice in orthopaedics, your presence and participation will enrich the conversation and contribute to a collective vision for the future.
I warmly invite you to join us in Kyoto in 2026. Together, let us build a bridge to the future—one that supports innovation, inclusivity, and improved musculoskeletal health for all.
Vikas Khanduja
SICOT President 2024 - 2026
Sakae Tanaka
SICOT 2026 Congress President
◆ 參會對象：醫生、醫院科室主任/副主任、住院醫師、醫院管理者、醫護人員以及從事該領域研究的科學家、研究人員、醫藥企業代表等等。
|
